Steroid 11β- hydroxylase deficiency congenital adrenal hyperplasia

Trends in Endocrinology and Metabolism

Volumn 19, Issue 3, 2008, Pages 96-99

  Nimkarn, Saroj ^a   New, Maria I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; AMILORIDE; ANDROSTENEDIONE; CALCIUM CHANNEL BLOCKING AGENT; CORTODOXONE; DEOXYCORTICOSTERONE; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; RENIN; SPIRONOLACTONE; STEROID 11BETA MONOOXYGENASE;

ADRENAL CORTEX; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG EFFECT; GENETIC ANALYSIS; HUMAN; HYPERTENSION; MUTATIONAL ANALYSIS; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; VIRILIZATION; GENETICS; METABOLISM; MUTATION;

ADRENAL CORTEX; ADRENAL HYPERPLASIA, CONGENITAL; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; MUTATION; STEROID 11-BETA-HYDROXYLASE;

EID: 41149159338     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.01.002     Document Type: Review

References (37)

1. Zachmann M., et al. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 56 (1983) 222-229
2. Curnow K.M., et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4552-4556
3. White P.C., et al. Genetic analysis of 11 beta-hydroxysteroid dehydrogenase. Steroids 59 (1994) 111-115
4. Khemiri M., et al. Tunis. Med. 84 (2006) 106-113
5. Rosler A., et al. High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. Am. J. Med. Genet. 42 (1992) 827-834
6. Paperna T., et al. Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews. J. Clin. Endocrinol. Metab. 90 (2005) 5463-5465
7. New M.I., and Seaman M.P. Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 30 (1970) 361-371
8. Mornet E., et al. Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J. Biol. Chem. 264 (1989) 20961-20967
9. al-Jurayyan N.A. Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency in Saudi Arabia: clinical and biochemical characteristics. Acta Paediatr. 84 (1995) 651-654
10. Rosler A., et al. Clinical variability of congenital adrenal hyperplasia due to 11B-hydroxylase deficiency. Horm. Res. 16 (1982) 133-141
11. Mimouni M., et al. Hypertension in a neonate with 11 beta-hydroxylase deficiency. Eur. J. Pediatr. 143 (1985) 231-233
12. Hague W.M., and Honour J.W. Malignant hypertension in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 18 (1983) 505-510
13. Chabre O., et al. Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1. J. Clin. Endocrinol. Metab. 85 (2000) 4060-4068
14. Peters C.J., et al. Cosegregation of a Novel Homozygous CYP11B1 Mutation with the Phenotype of Non-Classical Congenital Adrenal Hyperplasia in a Consanguious Family. Horm. Res. 67 (2007) 189-193
15. Joehrer K., et al. CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Hum. Mol. Genet. 6 (1997) 1829-1834
16. Clayton P.E., et al. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm. Res. 58 (2002) 188-195
17. Quintos J.B., et al. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86 (2001) 1511-1517
18. Stenson P.D., et al. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 21 (2003) 577-581
19. Geley S., et al. CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 81 (1996) 2896-2901
20. Hampf M., et al. Unequal crossing-over between aldosterone synthase and 11beta-hydroxylase genes causes congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86 (2001) 4445-4452
21. Portrat S., et al. Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86 (2001) 3197-3201
22. Rosler A., et al. Prenatal diagnosis of 11beta hydroxylase deficiency congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 49 (1979) 546-551
23. Schumert Z., et al. 11-Deoxycortisol in amniotic fluid: Prenatal diagnosis of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 12 (1980) 257-260
24. Sippell W.G., et al. Concentrations of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol, and cortisone determined simultaneously in human amniotic fluid throughout gestation. J. Clin. Endocrinol. Metab. 52 (1981) 385-392
25. Cerame B.I., et al. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. J. Clin. Endocrinol. Metab. 84 (1999) 3129-3134
26. New M., et al. Update: Prenatal diagnosis for congenital adrenal hyperplasia in 595 pregnancies. Endocrinologist 13 (2003) 233-239
27. Forest M.G., and Dorr H.G. Prenatal therapy in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Retrospective follow-up study of 253 treated pregnancies in 215 families. Endocrinologist 13 (2003) 252-259
28. Mercado A.B., et al. Extensive personal experience: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 80 (1995) 2014-2020
29. Motaghedi R., et al. Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J. Pediatr. Endocrinol. Metab. 18 (2005) 133-142
30. de Simone G., et al. Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension. Hypertension 7 (1985) 204-210
31. Connell J.M., et al. 11 beta-Hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: lessons for essential hypertension?. Endocr. Res. 22 (1996) 691-700
32. Keavney B., et al. Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. J. Clin. Endocrinol. Metab. 90 (2005) 1072-1077
33. Barr M., et al. Polymorphic variation in the 11beta-hydroxylase gene associates with reduced 11-hydroxylase efficiency. Hypertension 49 (2007) 113-119
34. Ganapathipillai S., et al. CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. J. Clin. Endocrinol. Metab. 90 (2005) 1220-1225
35. Imrie H., et al. Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. J. Clin. Endocrinol. Metab. 91 (2006) 5051-5056
36. White P.C., and Rainey W.E. Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. J. Clin. Endocrinol. Metab. 90 (2005) 1252-1255
37. New M.I., and Wilson R.C. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12790-12797